Florquinitau (18F)
Florquinitau ( 18 F), sold under the brand name Tauklarify, is a radioactive diagnostic agent used for positron emission tomography (PET) imaging.
≈ 1 min read
Florquinitau (18F). encyclopegia.org, snapshot enwiki-001377071843. /a/florquinitau-18f
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Florquinitau ( 18 F), sold under the brand name Tauklarify, is a radioactive diagnostic agent used for positron emission tomography (PET) imaging. It is given by intravenous injection. The most common side effects were headaches, nausea, injection site reactions, dizziness, and abdominal discomfort/pain. Florquinitau ( 18 F) was approved for medical use in the United States in August 2026.
Medical uses
Florquinitau ( 18 F) is indicated for positron emission tomography (PET) of the brain in adults with cognitive impairment who are being evaluated for Alzheimer's disease to identify people with tau neurofibrillary tangle (NFT) pathology.
Legal status
Florquinitau ( 18 F) was approved for medical use in the United States in August 2026.
Brand names
Florquinitau ( 18 F) is sold under the brand name Tauklarify.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1377071843 under CC BY-SA 4.0; modifications have been made.